“The clinical efficacy of integrating dolutegravir into the conventional therapeutic regimen for HIV management”, Int. J. Pharm. Sci. Drug Res., vol. 16, no. 6, pp. 940–948, Nov. 2024, doi: 10.25004/IJPSDR.2024.160603.